Peach allergy treatment test with microneedle patch
Part of Immune system & allergy clinical trials.
This study is testing a new way to treat peach allergy in people who are allergic to a protein called LTP. It uses tiny microneedle patches to slowly introduce the allergen to help your body become less reactive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 65 years old.
- You have a peach allergy caused by LTP (a protein in peaches), confirmed by a skin prick test or a blood test for Pru p 3.
- You are not pregnant or breastfeeding.
- You do not have an immune system disease, a serious mental health condition, or severe eczema.
- You are not taking medications that change how your immune system works or beta-blockers.
- Your lung function test (FEV1) is 70% or higher of normal.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called omalizumab for people with plant-food allergies caused by two specific proteins: LTP (found in peach skin) and profilin (found in melon). The goal is to see if the drug can help reduce allergic reactions.
This study is testing whether a natural fiber called pectin can help people who are allergic to peach (and sometimes peanut) due to a specific protein (LTP). You would eat pectin every day for a while and then have food challenges to see if your allergy gets better.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This trial tests an investigational medication called LP-003 to see if it can reduce allergic reactions to peanuts. It may help people who are allergic to peanuts be able to tolerate small amounts.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
Hear when a new Food Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.